{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:55:22Z","timestamp":1761519322258,"version":"3.37.3"},"reference-count":30,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,23]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Literature suggests that oncogenic osteomalacia is usually caused by a benign mesenchymal tumor secreting fibroblast growth factor subtype-23 (FGF-23), but the involvement of other phosphatonins has only been scarcely reported. We have previously published a seemingly typical case of oncogenic osteomalacia. Following curative neoplasm resection, we now report unique molecular characteristics and biology of this tumor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Description<\/jats:title><jats:p>A 25-year-old man had been diagnosed with severe oncogenic osteomalacia that gradually crippled him over 6 years. 68Ga-DOTA-TATE positron emission tomography\/computed tomography scan localized the culprit tumor to his left sole, which on resection revealed a deep fibrous histiocytoma displaying a proliferation of spindle cells with storiform pattern associated with multinucleated giant cells resembling osteoclasts. Circulating FGF-23, which was elevated more than 2-fold, declined to undetectable levels 24 h after surgery. Microarray analysis revealed increased tumor gene expression of the phosphatonins FGF-23, matrix extracellular phosphoglycoprotein (MEPE) and secreted frizzled-related protein subtype 4, with elevated levels of all 3 proteins confirmed through immunoblot analysis. Differential expression of genes involved in bone formation and bone mineralization were further identified. The patient made an astonishing recovery from being wheelchair bound to fully self-ambulant 2 months postoperatively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This report describes oncogenic osteomalacia due to a deep fibrous histiocytoma, which coincidentally has been found to induce profound muscle weakness via the overexpression of 3 phosphatonins, which resolved fully upon radical resection of the tumor. Additionally, genes involved in bone formation and bone remodeling contribute to the molecular signature of oncogenic osteomalacia.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgaa964","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T09:04:42Z","timestamp":1611047082000},"page":"e2299-e2308","source":"Crossref","is-referenced-by-count":5,"title":["Paraneoplastic Secretion of Multiple Phosphatonins From a Deep Fibrous Histiocytoma Causing Oncogenic Osteomalacia"],"prefix":"10.1210","volume":"106","author":[{"given":"Melvin Khee Shing","family":"Leow","sequence":"first","affiliation":[{"name":"Singapore Institute for Clinical Sciences (A*STAR), Brenner Centre for Molecular Medicine, Singapore"},{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Department of Endocrinology, Division of Medicine, Tan Tock Seng Hospital, Singapore"},{"name":"Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaillay","family":"Dogra","sequence":"additional","affiliation":[{"name":"Singapore Institute for Clinical Sciences (A*STAR), Brenner Centre for Molecular Medicine, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojia","family":"Ge","sequence":"additional","affiliation":[{"name":"Singapore Institute for Clinical Sciences (A*STAR), Brenner Centre for Molecular Medicine, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khoon Leong","family":"Chuah","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tan Tock Seng Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Liew","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Division of Medicine, Tan Tock Seng Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin Siu Hoong","family":"Loke","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7056-8887","authenticated-orcid":false,"given":"Craig","family":"McFarlane","sequence":"additional","affiliation":[{"name":"Singapore Institute for Clinical Sciences (A*STAR), Brenner Centre for Molecular Medicine, Singapore"},{"name":"Department of Molecular & Cell Biology, College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"issue":"1","key":"2021122204432663300_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol."},{"issue":"12","key":"2021122204432663300_CIT0002","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1210\/jc.2014-2120","article-title":"Ovarian cancer-related hypophosphatemic osteomalacia: a case report","volume":"99","author":"Lin","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"9949","key":"2021122204432663300_CIT0003","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(14)61186-7","article-title":"Oncogenic osteomalacia presenting as a crippling illness in a young man","volume":"384","author":"Leow","year":"2014","journal-title":"Lancet."},{"key":"2021122204432663300_CIT0004","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Florenzano","year":"2017","journal-title":"Bone Rep."},{"key":"2021122204432663300_CIT0005","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers."},{"year":"2020","author":"Leow","key":"2021122204432663300_CIT0006"},{"issue":"5","key":"2021122204432663300_CIT0007","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/eem.09.27","article-title":"Tumor-induced osteomalacia","volume":"4","author":"Farrow","year":"2009","journal-title":"Expert Rev Endocrinol Metab."},{"issue":"11","key":"2021122204432663300_CIT0008","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet."},{"issue":"2","key":"2021122204432663300_CIT0009","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1210\/en.2004-0766","article-title":"Skeletal overexpression of gremlin impairs bone formation and causes osteopenia","volume":"146","author":"Gazzerro","year":"2005","journal-title":"Endocrinology."},{"issue":"21","key":"2021122204432663300_CIT0010","doi-asserted-by":"crossref","first-page":"15872","DOI":"10.1074\/jbc.M701116200","article-title":"Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity","volume":"282","author":"Addison","year":"2007","journal-title":"J Biol Chem."},{"key":"2021122204432663300_CIT0011","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1242\/jcs.109.6.1597","article-title":"Modulation of osteoblast behaviour by tenascin","volume":"109 (Pt 6)","author":"Mackie","year":"1996","journal-title":"J Cell Sci."},{"issue":"9","key":"2021122204432663300_CIT0012","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/79683","article-title":"Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis","volume":"6","author":"Sabatakos","year":"2000","journal-title":"Nat Med."},{"issue":"1","key":"2021122204432663300_CIT0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol."},{"key":"2021122204432663300_CIT0014","volume-title":"Dahlin\u2019s Bone Tumors","author":"Unni","year":"2009","edition":"6"},{"issue":"2","key":"2021122204432663300_CIT0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4158\/EP10151.OR","article-title":"Tumor-induced osteomalacia: a single center experience","volume":"17","author":"Jagtap","year":"2011","journal-title":"Endocr Pract."},{"issue":"6","key":"2021122204432663300_CIT0016","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","article-title":"Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism","volume":"17","author":"De Beur","year":"2002","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2021122204432663300_CIT0017","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1152\/ajpendo.90201.2008","article-title":"Pathogenic role of Fgf23 in Dmp1-null mice","volume":"295","author":"Liu","year":"2008","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"2021122204432663300_CIT0018","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2859-6-4","article-title":"A perspective on microarrays: current applications, pitfalls, and potential uses","volume":"6","author":"Jaluria","year":"2007","journal-title":"Microb Cell Fact."},{"key":"2021122204432663300_CIT0019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/03008200390152061","article-title":"Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins","volume":"44","author":"Fisher","year":"2003","journal-title":"Connect Tissue Res."},{"issue":"3","key":"2021122204432663300_CIT0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/10454411000110030101","article-title":"Osteopontin","volume":"11","author":"Sodek","year":"2000","journal-title":"Crit Rev Oral Biol Med."},{"issue":"1","key":"2021122204432663300_CIT0021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1091\/mbc.e02-06-0354","article-title":"Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression","volume":"14","author":"Chellaiah","year":"2003","journal-title":"Mol Biol Cell."},{"issue":"6","key":"2021122204432663300_CIT0022","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1600-0765.1997.tb00563.x","article-title":"Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro","volume":"32","author":"Tani-Ishii","year":"1997","journal-title":"J Periodontal Res."},{"issue":"3","key":"2021122204432663300_CIT0023","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jbmr.2079","article-title":"Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice","volume":"29","author":"Yuan","year":"2014","journal-title":"J Bone Miner Res."},{"issue":"1-2","key":"2021122204432663300_CIT0024","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/19336918.2014.987587","article-title":"Tenascin-C: form versus function","volume":"9","author":"Giblin","year":"2015","journal-title":"Cell Adh Migr."},{"issue":"3-4","key":"2021122204432663300_CIT0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12079-009-0075-1","article-title":"The role of tenascin-C in tissue injury and tumorigenesis","volume":"3","author":"Midwood","year":"2009","journal-title":"J Cell Commun Signal."},{"key":"2021122204432663300_CIT0026","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2005.00332.x","article-title":"Fos\/AP-1 proteins in bone and the immune system","volume":"208","author":"Wagner","year":"2005","journal-title":"Immunol Rev."},{"issue":"1","key":"2021122204432663300_CIT0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jocd.2005.11.001","article-title":"Changes in bone mineral density following treatment of osteomalacia","volume":"9","author":"Bhambri","year":"2006","journal-title":"J Clin Densitom."},{"issue":"5","key":"2021122204432663300_CIT0028","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00268-004-7274-y","article-title":"Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism","volume":"28","author":"Nordenstr\u00f6m","year":"2004","journal-title":"World J Surg."},{"issue":"12","key":"2021122204432663300_CIT0029","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2011-1757","article-title":"The importance of whole body imaging in tumor-induced osteomalacia","volume":"96","author":"Chong","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122204432663300_CIT0030","first-page":"46","article-title":"Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET\/CT: a potential pitfall of standard-field imaging","volume":"19","author":"Kaneuchi","year":"2016","journal-title":"Hell J Nucl Med."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa964\/35922593\/dgaa964.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/5\/e2299\/41849158\/dgaa964.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/5\/e2299\/41849158\/dgaa964.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:42:47Z","timestamp":1724344967000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/5\/e2299\/6104231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,1,19]]},"published-print":{"date-parts":[[2021,4,23]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa964","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2021,1,19]]}}}